Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
283,333,333
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
63,677,801
-
Shares change
-
+4,704,875
-
Total reported value, excl. options
-
$987,988,866
-
Value change
-
+$64,674,674
-
Number of buys
-
37
-
Number of sells
-
-16
-
Price
-
$15.58
Significant Holders of Erasca, Inc. - Common Stock (ERAS) as of Q4 2021
73 filings reported holding ERAS - Erasca, Inc. - Common Stock as of Q4 2021.
Erasca, Inc. - Common Stock (ERAS) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63,677,801 shares
of 283,333,333 outstanding shares and own 22.47% of the company stock.
Largest 10 shareholders include FMR LLC (13,021,950 shares), ARCH Venture Management, LLC (11,055,554 shares), Cormorant Asset Management, LP (10,505,550 shares), PFM Health Sciences, LP (5,191,405 shares), HHLR ADVISORS, LTD. (4,722,221 shares), ALLIANCEBERNSTEIN L.P. (3,256,646 shares), Artal Group S.A. (3,172,221 shares), AH Equity Partners Bio II, L.L.C. (2,500,000 shares), BlackRock Inc. (1,888,445 shares), and ORBIMED ADVISORS LLC (1,667,693 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.